mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.5 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
0.2 |
0.5 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.5 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.18 |
0.5 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.5 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.5 |